Semaglutide is a weekly or daily GLP-1 receptor agonist that lowers appetite; it is the active ingredient in Wegovy, Ozempic and Rybelsus.
More weight than diabetes in Multnomah County
CDC PLACES estimates 28.9% of Multnomah County adults had obesity in 2023, against 9.5% with diagnosed diabetes [3]. Many Portland residents interested in semaglutide want it for weight, which points to Wegovy rather than Ozempic. Ozempic is labeled for type 2 diabetes only [5].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Portland, from $300 a month.
This is advertising, labeled as such. It is not a ranking.
Prices and ways to pay less
| Option | Monthly price | Source |
|---|---|---|
| Wegovy pen, standard self-pay | $349 | [1] |
| Wegovy pen, new patient starter doses (2 fills) | $199 | [1] |
| Wegovy pill | $149 to $299 | [1] |
| Commercial insurance with coverage, savings offer | As little as $25 | [1] |
Oregon coverage picture
KFF counted 13 Medicaid programs covering obesity GLP-1s in January 2026, and Oregon was not one of them [2]. Diabetes use is handled separately. For employer plans, ask whether Wegovy is on formulary and whether prior authorization applies.
What to expect from treatment
Wegovy's label starts at 0.25 mg weekly and steps up every 4 weeks to a 1.7 mg or 2.4 mg maintenance dose by week 17 [7]. In STEP 1, average weight loss at 68 weeks was 14.9% on 2.4 mg versus 2.4% on placebo [8]. Nausea affected 44% of people on 2.4 mg in trials [7]. See semaglutide results and side effects.
Choosing a prescriber
We could not confirm specific Portland hospital weight programs for this page. Check any prescriber with the Oregon Medical Board [9]. Compounded semaglutide is not FDA-approved, and FDA has warned about dosing errors with compounded injections [10]. Compare online semaglutide programs or read our Ro review.
Label warnings
Boxed warning for thyroid C-cell tumors; not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Stop and get care for severe stomach pain that will not go away. Watch for low blood sugar if you also take insulin or a sulfonylurea. Tell your surgeon or anesthesia team you take it before a procedure, and stop at least 2 months before a planned pregnancy [7]. Call 911 for emergencies such as a severe allergic reaction.
Other cities: Seattle, Sacramento, Salt Lake City. Guides: semaglutide, semaglutide near me.
Questions people ask
How much is semaglutide in Portland without insurance?
NovoCare lists the Wegovy pen at $349 a month and the Wegovy pill at $149 to $299, as of Oct 17 2026 [1].
Does Oregon Medicaid cover Wegovy?
Oregon was not among the 13 state Medicaid programs KFF counted as covering GLP-1s for obesity in January 2026 [2].
What is the obesity rate in Portland?
CDC PLACES estimates 28.9% of adults in Multnomah County, which includes most of Portland, had obesity in 2023 [3].
How does the Wegovy dose increase?
The label starts at 0.25 mg weekly and increases every 4 weeks (0.5, 1, 1.7 mg) to a maintenance dose from week 17 [7].
Can Medicare patients in Portland get Wegovy?
Eligible Part D enrollees pay $50 a month under the Medicare GLP-1 Bridge, which runs July 1 2026 to Dec 31 2027 [6].
How do I check an Oregon prescriber?
Use the Oregon Medical Board license search [9].
Sources
10 cited
- Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
- Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
- PLACES: County Data, Multnomah County, OR (2025 release, BRFSS 2023). CDC, 2023.
- QuickFacts: Portland city, Oregon. U.S. Census Bureau, 2025.
- Ozempic label. DailyMed, National Library of Medicine, May 2026.
- Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (PubMed), Feb 10, 2021.
- Oregon Medical Board. State of Oregon, Oct 17, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.